Evidence map›Paper›PMID 26586939›Full record

ArticleClinical interventions in aging2015

Elderly women who received Helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle mass.

Myong Ki Baeg, Myung-Gyu Choi, Sun-Hye Ko, Chul-Hyun Lim, Jin Su Kim, Yu Kyung Cho, Jae Myung Park, Young-Seok Cho, Bo-In Lee, In-Seok Lee

Open access · goldAbstract read
In one paragraph

Article in Clinical interventions in aging, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Effect ofGut and liver · 2025
    Article
  2. Article
  3. International journal of general medicine · 2025
    Review
  4. The impact ofFrontiers in cellular and infection microbiology · 2023
    Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Myong Ki BaegDepartment of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.
Myung-Gyu ChoiDepartment of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.
Sun-Hye KoDepartment of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.
Chul-Hyun LimDepartment of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.
Jin Su KimDepartment of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.
Yu Kyung ChoDepartment of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.
Jae Myung ParkDepartment of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.
Young-Seok ChoDepartment of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.
Bo-In LeeDepartment of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.
In-Seok LeeDepartment of Internal Medicine, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.
Catholic University of Korea · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSarcopenia is associated with adverse outcomes such as physical disability, poorer quality of life, and death. Helicobacter pylori (HP) eradication increases ghrelin secretion, which may be a possible treatment for sarcopenia. We investigated whether HP eradication reduces the risk of low muscle mass (LMM), which is an integral component of sarcopenia. MATERIALS AND

methodsHealthy, asymptomatic women aged ≥60 years who participated in a health screening program were enrolled. Subjects with a history of HP eradication were compared with those who were HP IgG(+), but had not received HP-eradicating therapy. Body composition was measured by multifrequency bioelectrical impedance analysis. LMM was defined as body muscle mass 2 standard deviations below the mean muscle mass of healthy women aged 20-39 years from the same program. Multivariable analysis was used to identify sarcopenia risk factors.

resultsThree hundred seventy-two women had received HP eradication, while 689 HP IgG(+) women had not. The prevalence of LMM was significantly lower in those who received HP eradication (13.7% vs 21.6%, P=0.002). Multivariable analysis identified risk factors for LMM as age, white blood cell count, serum total protein concentration, and the metabolic syndrome. HP eradication (odds ratio: 0.632, 95% confidence interval: 0.440-0.824, P=0.013) was a significant preventive factor, and exercise (odds ratio: 0.710, 95% confidence interval: 0.504-1.002, P=0.051) had a preventive tendency.

conclusionHP eradication might reduce LMM risk. This finding should be confirmed in prospective longitudinal studies to determine the long-term effects of HP eradication on sarcopenia.

Indexed as

AdultAgedAged, 80 and overAge FactorsBody Weights and MeasuresFemaleHealth BehaviorHealth StatusHelicobacter InfectionsHelicobacter pyloriHematologic TestsHumansMiddle AgedMuscle, SkeletalPrevalenceProspective Studiesbioelectrical impedance analysiseradicationHelicobacter pylorisarcopenia

Identifiers

PMID26586939
PMCPMC4634827
OpenAlexW1850830566

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.